Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa - Concepedia

Concepedia

Publication | Open Access

Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa

DOI Full Paper Access

199

Citations

16

References

2017

Year

Pablo A. Fraile-Ribot, Gabriel Cabot, Xavier Mulet, Leonor Periañez, María Luisa Martín-Pena, Carlos Juan, José Luis Pérez, Antonio Oliver

Journal of Antimicrobial Chemotherapy

Abstract

Modification of intrinsic (AmpC) and horizontally acquired β-lactamases appears to be the main mechanism leading to ceftolozane/tazobactam resistance in MDR P. aeruginosa.

References

	Year	Citations

Page 1